HSP90 inhibitor

Details for Australian Patent Application No. 2007268769 (hide)

Owner Chugai Seiyaku Kabushiki Kaisha

Inventors Fukami, Takaaki; Ono, Naomi; Na, Young-Jun; Shiratori, Yasuhiko; Kim, Sung-Jin; Miura, Takaaki; Tsukuda, Takuo; Hasegawa, Kiyoshi; Yamazaki, Toshikazu; Kawasaki, Ken-Ichi; Isshiki, Yoshiaki; Yoon, Dong-Oh; Komiyama, Susumu

Agent Spruson & Ferguson

Pub. Number AU-A-2007268769

PCT Pub. Number WO2007/138994

Priority 2006-146982 26.05.06 JP; 2007-094057 30.03.07 JP

Filing date 25 May 2007

Wipo publication date 6 December 2007

International Classifications

C07D 239/47 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61K 31/5377 (2006.01)

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 Drugs for specific purposes, not provided for in groups

Event Publications

11 December 2008 PCT application entered the National Phase

  PCT publication WO2007/138994 Priority application(s): WO2007/138994

14 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007268771-Novel crystal of 3-[5-[4-(cyclopentyloxy)-2hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6- yl)methoxy]phenyl]propionic acid

2007268749-Novel heterocyclic compound or salt thereof and intermediate thereof